A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Public ClinicalTrials.gov record NCT03067129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this study are to assess the pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir adult formulation in adolescents ages 12 to 17 years and a pediatric formulation of glecaprevir and pibrentasvir in children ages 3 to \< 12 years.
Study identification
- NCT ID
- NCT03067129
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 129 participants
Conditions and interventions
Conditions
Interventions
- Glecaprevir/Pibrentasvir Adult Formulation Drug
- Glecaprevir + Pibrentasvir Pediatric Formulation Drug
Drug
Eligibility (public fields only)
- Age range
- 3 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2017
- Primary completion
- May 20, 2020
- Completion
- Sep 11, 2022
- Last update posted
- May 8, 2023
2017 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of California San Francis /ID# 158002 | San Francisco | California | 94158 | — |
| Childrens Hospital Colorado /ID# 157996 | Aurora | Colorado | 80045 | — |
| CT Childrens Medical Ctr, US /ID# 158639 | Hartford | Connecticut | 06106 | — |
| UF Hepatology Research at CTRB /ID# 158008 | Gainesville | Florida | 32610-0272 | — |
| Advent Health /ID# 166022 | Orlando | Florida | 32803 | — |
| Indiana University /ID# 158001 | Indianapolis | Indiana | 46202 | — |
| Boston Childrens Hospital /ID# 157988 | Boston | Massachusetts | 02115 | — |
| Boston Medical Center /ID# 157997 | Boston | Massachusetts | 02118 | — |
| Columbia Univ Medical Center /ID# 158000 | New York | New York | 10032-3725 | — |
| UNC Health Care /ID# 157991 | Chapel Hill | North Carolina | 27514 | — |
| Cincinnati Childrens Hosp Med /ID# 158007 | Cincinnati | Ohio | 45229 | — |
| Children's Hospital of Philadelphia /ID# 158003 | Philadelphia | Pennsylvania | 19104 | — |
| Child Hosp of Pittsburgh,PA /ID# 158004 | Pittsburgh | Pennsylvania | 15213-2583 | — |
| Monroe-Carell Jr. Children's H /ID# 169037 | Nashville | Tennessee | 37232 | — |
| Baylor College of Medicine /ID# 157989 | Houston | Texas | 77030-3411 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03067129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03067129 live on ClinicalTrials.gov.